Principal Financial Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-16,835
| Closed | -$1.15M | – | 2606 |
|
2022
Q3 | $1.15M | Sell |
16,835
-108
| -0.6% | -$7.35K | ﹤0.01% | 1820 |
|
2022
Q2 | $541K | Sell |
16,943
-27,686
| -62% | -$884K | ﹤0.01% | 2037 |
|
2022
Q1 | $1.55M | Buy |
44,629
+26,620
| +148% | +$922K | ﹤0.01% | 1906 |
|
2021
Q4 | $527K | Sell |
18,009
-6,892
| -28% | -$202K | ﹤0.01% | 2111 |
|
2021
Q3 | $635K | Buy |
24,901
+983
| +4% | +$25.1K | ﹤0.01% | 2111 |
|
2021
Q2 | $838K | Buy |
23,918
+3,646
| +18% | +$128K | ﹤0.01% | 2080 |
|
2021
Q1 | $826K | Buy |
20,272
+407
| +2% | +$16.6K | ﹤0.01% | 2034 |
|
2020
Q4 | $860K | Sell |
19,865
-324
| -2% | -$14K | ﹤0.01% | 1974 |
|
2020
Q3 | $1.11M | Sell |
20,189
-1,545
| -7% | -$85.2K | ﹤0.01% | 1851 |
|
2020
Q2 | $1.37M | Buy |
21,734
+5,264
| +32% | +$332K | ﹤0.01% | 1770 |
|
2020
Q1 | $842K | Buy |
16,470
+95
| +0.6% | +$4.86K | ﹤0.01% | 1762 |
|
2019
Q4 | $1.3M | Sell |
16,375
-635
| -4% | -$50.5K | ﹤0.01% | 1792 |
|
2019
Q3 | $825K | Buy |
17,010
+1,546
| +10% | +$75K | ﹤0.01% | 1853 |
|
2019
Q2 | $813K | Buy |
15,464
+651
| +4% | +$34.2K | ﹤0.01% | 1873 |
|
2019
Q1 | $784K | Buy |
14,813
+709
| +5% | +$37.5K | ﹤0.01% | 1862 |
|
2018
Q4 | $579K | Sell |
14,104
-2,728
| -16% | -$112K | ﹤0.01% | 1884 |
|
2018
Q3 | $639K | Buy |
16,832
+2,463
| +17% | +$93.5K | ﹤0.01% | 1923 |
|
2018
Q2 | $650K | Buy |
14,369
+1,405
| +11% | +$63.6K | ﹤0.01% | 1918 |
|
2018
Q1 | $626K | Buy |
12,964
+74
| +0.6% | +$3.57K | ﹤0.01% | 1910 |
|
2017
Q4 | $507K | Buy |
+12,890
| New | +$507K | ﹤0.01% | 1958 |
|